by Vora Corporate Finance | Jul 3, 2021 | Financial Advisory, Insights, Merger & Acquisitions
Transaction: PharmEasy has signed a definitive agreement to acquire a majority stake in diagnostics firm Thyrocare Technologies Limited. Thyrocare Technologies Limited has agreed to sell approximately 66.14% of its equity share capital equivalent to 3,49,72,999 equity...
by Vora Corporate Finance | Jul 1, 2021 | Articles, Capital Market Updates, Merger & Acquisitions, Private Equity & IPO
Indian economy’s recovery pace moderated in Aprilon account of 2nd Covid 19 wave with record infections. Markets remained stable in this month but two IPOs were listed at discount. Key Deals include BYJU’s to acquire Aakash, Piramal to acquire Hemmo...
by Vora Corporate Finance | Jun 14, 2021 | Articles, Capital Market Updates, Merger & Acquisitions, Private Equity & IPO
The new year 2021 has begun on a strong positive note with vaccination drives ikn major economies as well as in India. The COVID-19 incidence is seen receding and economic recovery was seen. The economic survey and union budget were presented in February and their...
by Vora Corporate Finance | Jun 14, 2021 | Financial Advisory, Insights, Merger & Acquisitions, Private Equity & IPO
IIP numbers of April demonstrate that Indian Economy has remained resilient to Covid-19 2nd wave. At the same time, the stock markets have remained bullish in the month of May. Key Deals include New Mountain Capital backed Aceto acquiring Finar Limited, Adani Green...
by Vora Corporate Finance | Jun 14, 2021 | Insights
Covid 2nd wave hit India in late March and April. Impact of the same was seen on the Economy as well due to measures to curb Covid infections and state level restrictions. Ministry of Statistics and Programme Implementation (MOSPI) released the IIP (Index of...
